APA (7th ed.) Citation

CB, W., K, B., A, N., IN, M., S, D., H, H., . . . H, S. (2023). Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: An analysis of real-world outcomes. Haematologica, 108(11), 3025. https://doi.org/10.3324/haematol.2023.282780

Chicago Style (17th ed.) Citation

CB, Wagner, et al. "Effect of Cumulative Dose of Brentuximab Vedotin Maintenance in Relapsed/refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant: An Analysis of Real-world Outcomes." Haematologica 108, no. 11 (2023): 3025. https://doi.org/10.3324/haematol.2023.282780.

MLA (9th ed.) Citation

CB, Wagner, et al. "Effect of Cumulative Dose of Brentuximab Vedotin Maintenance in Relapsed/refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant: An Analysis of Real-world Outcomes." Haematologica, vol. 108, no. 11, 2023, p. 3025, https://doi.org/10.3324/haematol.2023.282780.